20:28 , Jul 31, 2019 |  BC Extra  |  Company News

Apelian to lead new T cell company BlueSphere

With serial biotech executive David Apelian as CEO, University of Pittsburgh and UPMC spinout BlueSphere debuted Wednesday with plans to move its personalized T cell therapies into the clinic. Pitt professors Mark and Warren Shlomchik,...